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客員教授 野村靖幸 （薬学博士）
本部門では，脳におけるニューロン・ニューロン間，およびグリア細胞・ニューロン聞の情報伝達機能
とその分子機構，ならぴにそれらへの和漢薬をはじめ諸種薬物の作用を研究している。すなわち，グリア
細胞における NO合成酵素（NOS）誘導の細胞内機構の解析と， NOのニューロンへの作用をニューロン
死およびノルアドレナリン放出作用の観点から検討を行っている。また，和漢薬や薬物の脳神経系機能へ
の行動薬理学的効果とその神経化学的作用機序に関する研究を行っている。さらにニューロンの各種モデ
ル細胞における受容体刺激応答機構と薬物作用を研究している。
本年度の研究内容と成果は下記の通りである。
I .グリア細胞における NO合成酵素誘導機構と NOのニューロンへの作用
ラット脳グリア細胞に対し， リポ多糖（LPS）は転写因子のNFxBを介し，一方IFNγはJaK2型の
チロシンキナーゼを介し， NOSを誘導することを示した。またグリア細胞で誘導された NOSは， kyotor-
phin (L-tyrosyl-L-arginine）を基質とし得ることを示した。こうして生成された NOは，ニューロンに
作用しアポトーシス様の細胞死を惹起すること，この作用に glyceraldehyde-3-phosphate dehy-
drogenaseが関与することを示唆した。一方NOはcysteineと反応し nitrosothiolとなって，ラット海馬
切片より noradrenaline放出を引き起こすことも示した。なお，NOの惹起するニューロンのアポトーシス
に関連し，アポトーシス抑制因子Bcl-2蛋白質の発現がCキナーゼによって促進され， Aキナーゼによっ
て抑制されることも示した。
II.和漢薬をはじめ薬物の神経精神機能への作用とその機序に関する研究
抗精神分裂病薬の長期投与がラット脳D2ドパミン受容体誘起のアデニル酸シクラーゼ活性抑制を消失
させること，また抗うつ薬rolipramの脳シナプス膜画分への結合，およびphosphodiesterase活性抑制が
加齢に伴い減少することを示した。さらに M1ムスカリン性受容体遮断薬やdantroleneの記憶障害誘起効
果から，記憶に M1受容体や細胞内Ca2＋動態が関わることを示した。丹参のメタノール抽出物が老化促進
モデルマウスの記憶障害を改善することを明らかにした。抗痴呆薬VA-045の脳シナプス膜画分への結合
の諸性質を示すとともに，運動障害モデルとしての自然発症振戦ウズラ（quail)脳におけるG蛋白質活性
の異常を示した。
II .ニューロンのモデル細胞やリンパ球における受容体応答機構に関する研究
ニューロンのモデルとしてのPC12細胞において，蜂毒ペプチドmasptoparanがノルアドレナIJン遊
離を引き起こすこと，ならびにこれに百日咳毒素感受性G蛋白質は関与しないことを見い出した。 P2プリ
ン受容体刺激に伴うアテゃニル酸シクラーゼ活性ならぴに細胞内Ca2＋濃度（[Ca2+] 1）の変化を示し，これ
らのノルアドレナリン遊離機構との関連性を示した。ニューロンのモデルNG108-15細胞において，セロ
トニン刺激は細胞内ニトロソ体より NOを生成させ，その結果cGMPレベルを上昇きせること，またJur-
ket細胞ではヒスタミン H1受容体刺激により［Ca2+]1が上昇することを示した。NG108-15細胞を Cキナ
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ーゼと Aキナーゼで同時処理すると発現する神経突起進展因子TA20mRNAの，発育期ラット脳におけ
る部位別発現の変化を示した。
以上の研究は北海道大学薬学部薬効学教室との共同研究として行われたものである。
I .グリア細胞における NO合成酵素誘導機構と
NOのニューロンへの作用
I -1. Possible Involvement of Tyrosine Kinase 
Activation in Lipopolysaccharide -Induced 
Expression of Ca2+-Insensitive But Cal-
modulin-Coupling Nitric Oxide Synthase in 
Rat Glial Cells 
To clarify the properties of an inducible type of 
nitric oxide synthase (i -NOS) in the brain, we 
examined whether lipopolysaccharide (LPS) 
induces NOS in glial cells cultured from neonatal 
rats. NOS activities ( N02 -accumulation and L 
[14C] citrulline formation) were detected by treat-
ment with LPS at 10 μg/ml for 6一72hr. L-[14C] 
citrulline formation by LPS induced i NOS was 
inhibited by NG-monomethyl-L-arginine (a NOS 
inhibitor) and diphenyleneiodonium (a flavoprotein 
inhibitor). The activity was not markedly changed 
in the presence or absence of Ca2+. The induction of 
i-NOS by LPS was abolished by cycloheximide, 
actinomycin D, or dexamethasone. In addition, the 
induction was inhibited by herbimycin A (a tyrosine 
kinase inhibitor), but was not by staurosporine, W-
7, or FK 506. After LPS stimulation, 130 kDa ・pro-
teins were reacted with anti-rat liver i-NOS anti-
body 5-72 hr. i-NOS induced from glial cells cou-
pied tightly with endogenous calmodulin (CaM) 
even in the absence of Ca2+. These results suggest 
that LPS induces expression of 130-kDa i-NOS 
th'.rough an activation of tyrosine kinase, after 
which i-NOS couples with CaM, and that NO is 
formed for 6 72 hr in glial cels. 
I -2. Possible involvement of Janus kinase Jak2 
in interferon-y induction of nitric oxide 
synthase in rat glial cells 
To clarify the induction pathway of inducible 
nitric oxide (NO) synthase in the brain, we 
examined the effects of interferon－γand lipopoly-
saccharide on the inducをionof inducible NO 
synthase in gljal cells cultured from neonatal rats, 
compared to those in the macrophage cell line 
RAW264.7 which was derived from Abelson leuke-
mia virus-induced BALB/c lymphocytic lymphoma. 
NO synthase activity (N02 -accumulation) and 130 
kDa protein of protein of inducible NO synthase 
were induced 24 h after treatment with interferon－γ 
or lipopolysaccharide in both glial cells and 
RA W264. 7 macrophages. These induction activities 
were inhibited by a tyrosine kinase inhibitor, her-
bimycin A. Immunoprecipitation assay using anti-
bodies against Janus kinases, and the signal trans司
ducer and activator of transcription 1 (ST A Tl), 
revealed that interferon－γinduced tyrosine pht>s-
phorylation of the just another kinase 2 (Jak2) and 
STA Tlαbut did not induced the phosphorylation of 
J akl, the non receptor tyrosine kinase-2 (Tyk2) 
and STATlβ. Tyrosine phosphorylation of J ak2 
and STATlαinduced by interferon一γwasalso 
inhibited by herbimycin A, while lipopolysaccharide 
did not induce any tyrosine phosphorylation of 
Janus kinases and STATl at al. These results 
suggest that the interferon-y-induced inducible NO 
synthase induction involves activation of J ak2 
STA Tlαpathway in both glial cells and macro-
phages. 
I -3. Kyotorphin (L-tyrosyl-L-arginine) as a 
possible substrate for inducible nitric oxide 
synthase in rat glial cells 
L -Arginine (L-Arg) is an endogenous substrate 
for nitric oxide synthase (NOS). In the present 
study, we examined whether L-tyrosyl-L Arg 
( kyotorphin) , an endogenous analgesic neuropep-
tide, might be a substrate for inducibre NOS 
(iNOS) in the brain. Both kyotorphin and L-Arg 
caused an accumulation of nitrites in lipopolysac-
charide (LPS) -treated glial cells cultured from 
infant rat brains. However, such accumulation of 
nitrites was not induc.P.d by NG-nitro-L -Arg (a 
NOS inhibitor), L tyrosyl-D-Arg (D-kyotorphin) or 
D-Arg. L-Leucyl-L-Arg (an antagonist for kyotor-
phin receptors) or bestatin (an inhibitor for kyotor-
phin -hydrolyzing peptidase) did not inhibit the 
kyotorphin induced accumulation of nitrites in LPS 
-treated cels. On the contrary, L Leucyl-L -Arg 
caused an accumulation of nitrites in a concentra-
tion-dependent manner. The results indicate that 
nitr~ic oxide (NO) is produced in LPS treated glial 
cells directly from kyotorphin through the catalytic 
action of iNOS. 
I -4. Neuronal Apoptosis by Glial NO : Involve-
ment of Inhibition of Glyceraldehyde -3 -
Phosphate Dehydrogenase 
In primary cocultures of neurons and glial cells 
prepared from the neonatal rat brain, lipopolysac-
charide (LPS) reduced the numbers of neuronal 
cells but the effects were markedly inhibited by NG 
-monomethyl-L-arginine, indicating the involve-
ment of NO and LPS induced NO synthase in 
neuronal death. LPS stimulated the expression of 
inducible NOS (iNOS) in preparations of primary 
cultured microglias/ astrocytes, but not in primary 
cultured neurons. In addition, LPS caused DNA 
fragmentation only in NG108-15 cells but not in 
primary cultured astrocytes as well as astrocytes in 
cocultures of the two cell types, suggesting that 
NOS induces the apoptosis of neurons but not glial 
cels. We then examined the NO induced neuronal 
death in NG108-15 cells using NO donors. SNP, an 
NO donor, caused N02 -accumulation in the reac-
tion medium and lactate dehydrogenase (LDH) 
leakage from NG108 -15 cells. Although SNP 
stimulated guanylyl cyclase and accumulated 
cGMP, cGMP analogs did not affect LDH leakage. 
In addition, SNP induced chromosomal condensa-
tion and fragmentation of nuclei in NG108 15 cels. 
Gel electrophoretic analysis of cellular DNA 
extracted from SNP-treated cels, confirmed the 
internucleosomal DNA fragmentation typical of 
apoptosis in this culture. SNP increased the amount 
of radiosotopic labeled glyceraldehyde 3 phosphate 
dehydrogenase (GAPDH) in the presence of [32P] 
NAD and inhibited the enzyme activity. The results 
suggested that SNP jnduced cell death is partly due 
to the NO-induced inhibition of GAPDH, perhaps 
by stimulating the binding of NAD to GAPDH. 
I -5. Sodium nitroprusside stimulates nor-
adrenaline release from rat hippocampal 
153 
slices in the presence of dithiothreitol 
It is becoming apparent that nitrogen monoxide 
(NO) such as nitric oxide has regulatory roles for 
neuronal cell functions. We examined the role of 
NO using NO donors on [3H]noradrenaline (NA) 
release from prelabeled rat hippocampal slices. 
Sodium nitroprusside (SNP), which had no effect 
by itself, stimulated [3H] NA release in a dose-
dependent manner (ED50=0.5 mM) in the presence 
of dithiothreitol (DTT). The stimulatory effect of 
SNP with DTT, but not high-K+, was observed in 
an extracellular Ca2+ free buffer. The maximal 
effect of SNP was obtained after incubation for 1-
2 h with DTT in buffer at physiological pH (7.4). 
The simultaneous addition of SNP and DTT to the 
slices induced a small effect, and the effect of SNP 
declined after 3.5 h. SNP stimulated cyclic GMP 
accumulation in the slices without DTT. NaN02 
and 1 hydroxy 2 oxo 3,3 bis (2-aminoethyl) -1-tri-
azene (a generator of nitric oxide), which stimulat-
ed cyclic GMP accumulation by themselves, did not 
stimulate [3H] NA release in the presence and 
absence of DTT. 3 Morpholinosydnonimine HCl (a 
generator of peroxynitrite) had no effect on the 
release. The stimulatory effect of SNP and DTT on 
NA release was inhibited 40 % by nitric oxide scav-
engers such as oxyhemoglobin and 2-(4 carboxy-
phenyl) -4,4ム5-tetramethylimidazoline -1 -oxy-3 
oxide, although cyclic GMP accumulation induced 
by NO donors was completely inhibited. These 
findings suggest that SNP reacts with DTT to 
produce unknown active species, and that cyclic 
GMP is not a mediator for SNP-stimulated NA 
release. 
I -6. NO Donors Stimulate Noradrenaline Re-
lease From Rat Hippocampus in a Cal-
modulin-Dependent Manner in the Pres-
ence of L-Cysteine 
Nitrogen oxides (NO) such as nitric oxide have 
been suggested to potentiate neurotransmitter 
release in a variety-of neuronal cels. In this study, 
we showed that NO donors stimulate the release of 
noradrenaline (NA) from rat hippocampus both in 
vivo and in vitro. Co-addition of NO donors (sodium 
nitroprusside [SNP] or S nitroso N acetylpenicil・
!amine [SN AP]) and thiol compounds (dithioth-
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reitol [DTT] or L-cysteine) stimulated [3H] NA 
release from prelabeled hippocampal slices. Mi-
crodialysis in freely moving rats was used to ascer” 
tain the role of NO in control of NA release from 
the hippocampus in vivo. Co-addition of SN AP and 
L -cysteine stimulated endogenous NA release 
within 30 min. The concentration of NA peaked 
between 30-60 min to almost 3 times basal level. 
Another thiol compound, glutathione, had no effect 
on [3H]NA release in the presence of SNP or 
SNAP. In the presence of SNAP, the effect of L 
cysteine was much higher than that of the D -
isomer, although SNAP did not show ster-
eospecificity. The effect of SNAP/ L-cysteine was 
rapid and the maximal increase in [3H]NA release 
was attained 0-1 min after application, which was 
similar in time course to the effect of KC!. Unlike 
the release by KCl, SN AP ILcysteine-stimulated 
NA release was independent of extracellular CaCl2・
However, pretreatment with the calmodulin antago-
nists W-7 or trifluoperazine significantly reduced 
the SNAP/L-cysteine stimulated [3H]NA release. 
Formation of nitric oxide and activation of 
guanylate cyclase by nitric oxide were not respon-
sible for SN AP IL cysteine stimulated NA release. 
These findings suggest that NO donors stimulate 
NA release from the hippocampus in the presence of 
thiol compounds such as L-cysteine in vivo and in 
vitro in a calmodulin dependent, Ca2+-and cyclic 
GMP independent manner. The physiological roles 
of thiol compounds such as L-cysteine or glutath-
ione as intermediates of NO are discussed. 
I -7 . Regulation of Bcl-2 Protein Expression in 
Human N euroblastoma SH -SY5Y Cells : 
Positive and Negative Effects of Protein 
Kinases C and A, Respectively 
The regulatory mechanism of Bel -2 protein 
expression was investigated in SH SY5Y cels, the 
human neuroblastoma cell line that expresses 
natively Bel 2 proteins. When the cells were treated 
with 12-0-tetradecanoylphorbol 13-acetate (TPA) 
or retinoic acid, the level of Bel 2 protein was 
increased compared with the control. These effects 
were inhibited by pretreatment with a protein 
kinase C (PKC) inhibitor, staurosporine or calphos-
tin C. The level of Bel 2 protein was also increased 
by treatment with carbachol, a muscarinic acetyl-
choline receptor (mAChR) agonist, and the effects 
were also inhibited by pretreatment with staur-
osporine or calphostin C. In addition, a carbachol-
induced increase in Bcl-2 protein levels and a tran-
sient elevation of [Ca2+] 1 were inhibited by pretreat-
ment with 4 DAMP (4-diphenylacetoxy-N meth-
ylpiperidine), an m3 mAChR antagonist. In contrast, 
the level of Bel 2 protein was decreased by treat-
ment with dibutyryl cAMP (diBu-cAMP), fors-
kolin, or cholera toxin, and the effects of diBu-
cAMP were inhibited by pretreatment with a pro-
tein kinase A (PKA) inhibitor, H-89. From these 
results, we suggest that the expression of Bel 2 
proteins is regulated by PKC and PKA in positive 
and negative manners, respectively, in SH SY5Y 
cels. Furthermore, the nucleosomal DNA fragmen-
tation induced by serum depletion for 4 h was ob-
sereved in SH SY5Y cells when the level of Bel 2 
protein was down-regulated by treatment with 1 
mM diBu cAMP for 3 days, although the DNA 
fragmentation by serum depletion for 4 h was not 
observed in nontreatment cels, indicating that Bel-
2 proteins whose expression is regulated by PKC 
and PKA play important roles in serum depletion-
induced apoptosis. 
II.和漢薬をはじめ薬物の神経精神機能への作用
とその機序に関する研究
11-1. Long-term neuroleptic treatments counter-
act dopamine D2 agonist inhibition of 
adenylate cyclase but do not affect pertussis 
toxin ADP-ribosylation in the rat brain 
We have investigated the response of adenylate 
cyclase to GTP and to dopamine (DA) in striatal 
membranes of rats treated for 3 weeks with chlor-
promazine or haloperidol, and further measured the 
level of Gi (an inhibitory GTP-binding protein) or 
Go (a similar GTP-binding protein of unknown 
function) in 3 areas (cerebral cortex. striatum and 
hippocampus) utilizing pertussis toxin -catalyzed 
ADP ribosylation. In saline-treated control mem-
branes, GTP exerted a biphasic effect on basal and 
DA-stimulated enzyme activity-peak levels of stim-
ulation by DA plus GTP were observed at 1 μM 
GTP. Conversely, dopaminergic inhibitory effects 
at 10-100 μM GTP were completely attenuated in 
chlorpromazine or haloperidol-treated membranes. 
D2 inhibition of adenylate cyclase by the selective 
D2 agonist PPHT was also attenuated due to these 
neuroleptic treatments, while an increase in D2 
receptor binding was observed. The pertussis toxin 
ADP-ribosylation of G-proteins (Gi/Go) did not 
differ significantly in any area. This indicates that 
long term neuroleptic treatments increased D2 rece-
ptor binding, but attenuated D2 inhibition of 
adenylate cyclase, and exercised no influence on 
pertussis toxin ADP-ribosylation. 
I -2. Influence of Aging on Rolioprarn-Sensitive 
Phosphodiesterase Activity and [3H]Roli-
pram Binding in the Rat Brain 
To clarify the quantitative and qualitative 
changes in type IV phosphodiesterase (PDE IV) 
with aging, phosphodiesterase (PDE) activity and 
[3H] rolipram binding in the cytosolic fraction from 
the brains of young and aged rats were examined. In 
al areas of the aged (100-week old) rat brain 
except for hippocampus, the PDE activity was 
decreased by about half that the young (10-week-
old) animals. However, inhibition % by 100 μM 
rolipram and by 100 μM isobutylmethylxanthine 
(IBMX) was not significantly different between the 
aged and young rats. On the other hand, [3H]roli-
pram binding and rolipram-sensitive PDE activity 
did not change with aging in the hippocampus, 
although both were decreased in other brain 
regions. These results suggest出atPDE IV does not 
decrease with aging and maintains its cAMP 
degrading activity in the hippocampus. It may be 
involved in the dysfunction of the hippocampus with 
agmg. 
11-3. Effects of Selective Muscarinic Antago-
nists, Pirenzepine and AF-DX 116, on Pas-
sive Avoidance Tasks in Mice 
To clarify the physiological roles of muscarinic 
acetylcholine (mACh) receptor subtyp田，M1andM2, 
on learning and memory, we examined the effects of 
three antagonists, atropine (non-selective) , pirenze-
pine (M1 selective) and 11 [ [2 [ (diethylamino) 
methy日一1-piperidinyl] acetyl]一5,11-dihydro -6H -
pyrido [2,3-b] [1,4]benzodiazepine-6-one, AF-DX 
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116 (M2 selective), on step-through passive avoid-
ance tasks in mice. During acquisition tests, mice 
were trained repeatedly until they achieved crite-
rion latency (300s). In al experiments, drugs or 
vehicles were intracerebroventricularly administer-
ed. Pre-tr討ning(5 min before) administration of 
atropine (1 40 nmol) and pirenzepine (10 and 40 
nmol) shortened the response latency in retention 
tests at 14d after acquisition training. Pre-test (5 
min before) and post training (immediately after 
the acquisition training) administration of atropine 
slightly but not significantly impaired retention 
scores. The administration of AF-DX 116 did not 
apparently affect the scores in any of tests. Thus, 
the M1 receptor subtype coupling systems seem to 
be more important in the acquisition-consolidation 
process rather than in the retrieval process. 
I -4. 1-[[[5 -( 4-Nitrophenyl)-2-furany ]meth・
ylene]irnino]-2,4-irnidazolidinedione 
(Dantrolene), an Inhibitor of Intracellular 
Ca2+ Mobilization, Impairs Avoidance Per-
forrnance and Spatial Memory in Mice 
Effects of the intracerebroventricular administra-
tion of 1-[[[5-(4-nitrophenyl)ー2-furanyl]meth-
ylene] imino] 2,4 -imidazolidinedione (dantrolene, 
an inhibitor of intracellular Ca2+ mobilization) on 
learning/memory were investigated in mice using 
step -througt passive avoidance and radial -arm 
maze tests. In the passive avoidance test, the admin-
istration of 6 nmol of dantrolene shortened the 
response latency in the retention test. The number 
of times of acquisition training required to achieve 
the criterion latency (300s) did not change in the 
acquisition test. Ten nmol of administration of 
dantrolene increased the number of times of acquisi-
tion training required to achieve the criterion 
latency in the acquisition test and shortened the 
response latency in the retention test. In the radial 
-arm maze tests, 20 nmol of administration of 
dantrolene disrupted maze choice accuracy and 
increased error numbers. These results suggest that 
intraneuronal Ca2+ mobilization plays important 
roles in learning and memory. 
11-5. Ameliorating Effects of Dan-Shen Meth-
anol Extract on Cognitive Deficiencies in 
Senescence-Accelerated Mouse 
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Effect of the long-term treatment with a Dan-
Shen （品lv勿emiltiorrhizae radix) methanol extract 
(DME) on memory and learning in scenescence 
accelerated mouse was investigated by means of 
Morris’s water maze task. DME treatment signifi幽
cantly decreased the escape latency and floating 
time in the PS strain of senescence -accelerated 
mouse (SAMP8), which strain spontaneously 
develops learning deficits. These results suggest 
that DME treatment improved spatial learning and 
activated emotional function. In neurochemical 
investigation, although no effect on choline acetyl 
transferase activity or [3H] QNB (quinuclidinyl 
benzilate) binding was observed, DME treatment 
caused increases in [3H] MK-801 ( ( +)-5-methyl 10, 
11-dihydro 5H-cdibenzo [a, b] cyclohepten-5,10 
imine maleate) binding to the cortical membrane 
fraction and [3H]NNA (NG nitro-L-arginine) bind-
ing to the cytosolic fraction of the brain stem, and 
decreased [3H] PD Bu (phorbol 12,13 -dibutyrate) 
binding to membranes from the hippocampus, 
striatum, and cerebellum. Thus, our data suggests 
that long-term DME treatment improves spatial 
learning and emotional functions in SAMP8. As to 
the mechanism, DME吐reatmentenhances cortical 
glutamatergic excitatory neurotransmission and 
nitric oxide synthase -related functions in brain 
stem, and affects hippocampal and striatal func-
tions mediated by protein kinase C. 
I -6. Partial Characterization of Binding Sites 
of VA -045, a Novel Apovincaminic Acid 
Derivative, in Rat Brain Membranes 
We characterized the binding sites of VA-045 
[ ( +)-eburunamenine 14 carboxylic acid (2 nitrox-
yethyl) ester] in the rat brain. V A-045 showed no 
affinity for various types of well known neurotrans-
mitter -related receptors or channels. However, 
radiolabeled V A-045 ( [3H] V A-045) bound to rat 
brain membranes in a saturable and reversible 
manner. The Kd and Bmax values of [3H] V A-045 
binding were 58.2 nM and 2685 fmol/mg of protein, 
respectively. The largest specific binding of [3H] 
VA 045 was observed in the cerebellum, among 
seven brain regions, and in subcellular 
synaptosomes. Specific binding of [3H] VA 045 was 
inhibited by V A-045 (K;=0.06 μM), a levorotatory 
enantiomer of V A-045 (VA 213) and its structural 
analog, vinpocentine. Moreover, compounds with 
calmodulin antagonistic activity inhibited the [3H] 
VA-045 binding. These results suggest that VA 045 
binds to specific sites, which may resemble cal-
modulin, on synaptic membranes in the brain. 
I -7 . Changes of GTP binding proteins, not neuro-
filament-associated proteins, in the brain 
of the neurofilament -deficient quail 
“Quiver” 
A neurofilament (NF) deficient mutant of the 
Japanese quail was named “Quiver”， as it showed 
generalized quivering as a clinical sign. NF consists 
of three major subunits ; low, middle and high. We 
previously reported that the noradrenaline and 5 
hydroxytrptamine content in the neostriatum of the 
Quiver’s brain was different from that in the normal 
quail, although disappearance of the three NF pro-
teins occurred in al areas of the Quiver’s brain. 
Thus, NF related proteins may show considerable 
changes in the specific sites of Quiver’s brain. In this 
study, an examination was made of the changes in 
NF related proteins in the Quiver, by immunoblot-
ting analysis. The amounts of cyclin -dependent 
kinase 5 (cdk5), which phosphorylates NF proteins, 
and tau which is a substrate of cdk5, in the neo-
striatum of the Quiver, were essentially the same as 
those in the normal quail, although NF proteins 
could not be detected in the Quiver. The amount of 
αtubulin in the Quiver’s brain was similar to that 
in the normal quail. Next, we investigated the 
changes of GTP binding (G) proteins in the Quiver’s 
brain, because cytoskeletal components such as 
tubulin and F -actin bind with G proteins. [32P] ADP 
ribosylation of G proteins (Gs by cholera toxin and 
Gi/G0 by pertussis toxin) in the neostriatum of the 
Quiver increased significantly, although αsubunits 
of G proteins showed no change by immunoblotting 
analysis. The ratios of the trimer form in G proteins 
thus appear to increase more in the NF-deficient 
Quiver brain than in the brain of the normal quail. 
The G proteins mediated adenylate cyclase activ-
ities were the same in the brain of both the Quiver 
and the normal quail. Possible interactions between 
NFs and G proteins are discussed. 
I .ニューロンのモデル細胞やリンパ球における
受容体応答機構に関する研究
Hト1.Pertussis Toxin-Insensitive Effects of Mas-
toparan, A Wasp Venom Peptide, in PC12 
Cells 
Recent studies have shown that mastoparan, an 
amphiphilic peptide derived from wasp venom, 
modifies the secretion of neurotransmitters and 
hormones from a variety of cell types. Mastoparan 
interacts with heterotrimeric guanine nucleotide-
binding proteins (G proteins) such as Gi and G。，
which are ADP -ribosylated by pertussis toxin 
(PTX) and thereby uncoupled from receptors. Pre-
viously, some of the effects of mastoparan including 
secretion were reported to be modified selectively 
by PTX but not by cholera toxin (CTX). In the 
present study, we examined the influence of bacte-
rial toxins on the effects of mastoparan in PC12 
cels. Mastoparan stimulated [3H]noradrenaline 
(NA) release from prelabeled PC12 cells in the 
absence of CaCl2, although high K+ or ATP 
stimulated the release in a Ca2+ dependent manner. 
Pretreatment with CTX, not PTX, for 24 h inhibited 
mastoparan stimulated [3H]NA release. Mastopar-
an inhibited forskolin-stimulated cyclic AMP accu-
mulation in a dose -dependent manner, although 
mastoparan had no effect by itself. Pretreatment 
with PTX completely abolished the inhibitory effect 
of carbachol via G1 on cyclic AMP accumulation 
and partially reduced the effect of mastoparan. 
However, the inhibitory effect of 20 μM mastopar-
an was not modified by pretreatment with PTX. 
Thus. we investigated the effect of mastoparan on 
CTX catalyzed [32P]ADP ribosylation of proteins 
in PC12 cels. A subunit of CTX (CTX-A) catal-
yzed [32P] ADP-ribosylation of many proteins in the 
cytosolic fraction of PC12 cels. One of these was a 
20 kDa protein, named ADP -ribosylating factor 
(ARF) . The addition of mastoparan to assay mix -
tures inhibited ADP ribosylation of many proteins 
including ARF and CTX A in the presence of the 
cytosolic fraction. In the absence of the cytosolic 
fraction, however, mastoparan slightly enhanced 
ADP -ribosylation of bovine serum albumin and 
auto ADP ribosylation by CTX-A. Mastoparan did 
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not inhibit ADP ribosylation of the αsubunit of Gs 
in the membrane fraction. These findings suggest 
that 1) mastoparan interacts with PTX insentitive 
and CTX sensitive factor (s) to stimulate NA 
release, and 2) mastoparan interacts with ARF in-
hibiting its activity to enhance the ADP ribosyla-
tion reaction by CTX. ARF, may be an exocytosis-
linked G protein. 
I -2. P 2 purinoceptor -mediated stimulation of 
adenylyl cyclase in PC12 cells 
PC12 pheochromocytoma cells have P 2 purinocep-
tors which are activated by ATP and coupled to 
Ca2+ influx and catecholamine release. Also PC12 
cells have adenosine receptors coupled positively to 
acienylyl cyclase, and cyclic AMP regulates cell 
functions such as catecholamine release. The effects 
of ATP and ATP analogs on cyclic AMP accumula-
tion in PC12 cells were investigated in this study. 
ATP and adenosine 5’－ 0 -(3 -thiotriphosphate) 
stimulated cyclic AMP accumulation at low concen-
trations up to 300 μM but showed inhibitory effects 
above this concentration. 2',3’－0-(4 Benzoyl) ben-
zoyl ATP and 2 methylthio ATP showed similar 
effects, although the responses were very limited. 
Addition of adenosine 5’0 -(2 thiodiphosphate) 
(ADPβS) orβ，y-methylene ATP, but not α，β－ 
methylene ATP, stimulated cyclic AMP accumula-
tion markedly without causing an inhibitory phase. 
The effects of ATP, ADPβS and β，γ－methylene 
ATP were not inhibited by adenosine deaminase or 
specific antagonists to A1 and A2 adenosine recep-
tors. Neither ADPβS norβ，γ－ methylene ATP 
showed any effect on Ca2+ influx or noradrenaline 
release. Suramin, a P 2 receptors antagonist, had no 
inhibitory effect against ATP analog stimulated 
cyclic AMP accumulation, although reactive blue 2 
inhibited the β，γ－methylene ATP-stimulated reac-
tion but not that up regulated by ADPβS. These 
findings suggest that the pharmacological charac-
teristics of these ATP receptors coupled to adenylyl 
cyclase are clearly different from those of ligand-
gated ion channels defined by P zxpurinoceptors, 
which have been cloned and shown to be coupled to 
Ca2+ influx and catecholamine release in PC12 cels. 
The existence of a new type of P 2 purinoceptor-
mediating stimulation of adenylyl cyclase is 
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proposed in PC12 cells. 
Hト3.Go Protein Does Not Regulate ATP-
Stimulated [ Ca2+]1 Elevation or Nor-
adrenaline Release in PC12 Cells 
The roles of Go, a heterotrimeric GTP binding 
(G) protein with a 40-kDaαsubunit and which is 
localized predominantly in neuronal cells, in 
exocytosis have been discussed recently. PC12 pheo-
chromocytoma cell line is a convenient model in 
which to study the Caz+ dependent mechanisms of 
the neurosecretory process. The stimulation of ATP 
receptors or addition of KCl stimulated an elevation 
of cytosolic free Ca2+ concentration ([Ca2+]1) and 
[3H]noradrenaline (NA) release in PC12 cels. In 
this study, we investigated the roles of Go in ATP 
and KCl stimulated reactions. Nerve growth factor 
treatment for 2 days and transfection of PC12 cells 
with cDNA of subunit of Go (Goα） had no effect on 
ATP -stimulated [3H] NA release, although both 
treatments increased levels of the Goαand its 
trimeric form by about twofold over those in un-
stimulated cels. The [ Ca2+] 1 rise induced by ATP 
in NGF treated cells was similar to that in control 
cels, although the maximal response was slightly 
smaller. Cholera toxin treatment for 2 days inhib-
ited ATP -and KCl -stimulated NA release, 
although this treatment caused an approximately 
twofold increase in the level of Go. Pertussis toxin 
treatment, which ADP ribosylated over 90 % of 
endogenous G proteins such as Go, had no effect on 
ATP -stimulated reactions. These findings show 
that Go does not directly regulate ATP-stimulated 
Ca2+ channels or the NA release process in PC12 
cels. Cholera toxin sensitive protein (s) may regu-
late exocytosis. 
Hト4.Cyclic GMP Elevation by 5-Hydroxytrypta-
mine Is Due to Nitric Oxide Derived from 
Endogenous Nitrosothiol in NG108-15 Cells 
To clarify the involvement of nitric oxide (NO) 
derived from nitrosothiols (RSNO) in 5-hydroxy-
tryptamine (5 HT) induced Ca2+ independent 
cGMP formation (CIGF) in NG108-15 cels, we 
investigated the effects of 5 HT on intracellular 
contents of RSNO as well as of NO metabolites. 5 
HT stimulation resulted in an increase in the 
intracellular contents of nitrate and cGMP. RSNO 
was detected in NG108-15 cells and was decreased 
by 5 HT stimulation. Furthermore, the time course 
of nitrate increase was coincident with that of 
RSNO decrease. Carboxy PTIO inhibited 5-HT-
induced CIGF, whereas oxyhemoglobin failed to 
inhibit it. The data suggest that NO isstored in a 
stable form as RSNO and that 5-HT stimulates NO 
generation from endogenous RSNO, which is fol-
owed by elevation of cGMP via activation of 
cytosolic guanylyl cyclase by NO in NG108 15 cells. 
We suggest the existence of a novel 5-HT signal 
transduction pathway involved in NO generation in 
NG108-15 cels. 
II -5. Regulation of [Ca2十］1Rise Activated by 
Doxepin-sensitive H 1-Histamine Receptors 
in Jurkat Cells, Cloned Human T 
Lymphocytes 
To clarify the presence of histamine receptor and 
its transmembrane mechanism in human T 
lymphocytes, we investigated the effects of agonists 
or antagonists of histamine receptor subtypes and 
bacterial toxins on intracellular concentration of 
Ca2+ ( [Ca2+] 1U3H] pyrilamine binding and c fos 
mRNA expression in Jurkat cels, cloned human T 
lymphocytes. H1 agonists (histamine and 2-methyl-
histamine) caused a transient rise of [Ca2+] 1 and H1 
antagonists (pyrilamine and doxepin) inhibited the 
histamine induced [Caz+ J 1rise more potently than 
the H2-antagonist (cimetidine) on the H3-antago-
nist (impromidine). Binding parameters of [3H] 
pyrilamine binding were Kct=5.53 nM and呂田x二2,647
sites/ cel. Pretreatment with B.ρertussis, V. chol-
era. or C. botulinum toxin did not influence his-
tamine induced [Caz+] 1 rise. Western Blot analysis 
using antibodies against subunits of GTP binding 
proteins indicated that Gq/ G11 richly existed in 
Jurkat cels. Histamine induced mRNA expression 
of an immediate early gene c-Jos. Pretreatment 
with a protein kinase C activator, phorbol 12 myris-
tate 13-acetate, caused almost complete inhibition 
of histamine induced [Ca2つirise, but did not do so 
by activators of cAMP-and cGMP-dependent pro-
tein kinases. 
III-6. Expression of mRN A for a neuronal differ-
entiation factor, TA20, in developing rat 
brains 
In our previous study, a novel factor, T A20, was 
isolated from NG108-15 cels. The TA20 mRNA 
was increased by stimulation which also induced 
neuronal differentiation. Neuronal cells overex-
pressed with T A20 extended long neurites and 
stopped cel growth (Tohda et al., 1995, Neurosci. 
Res., 23 ; 21-27). We investigated the expression 
pattern of T A20 mRN A in developing rat brains to 
predict physiological roles of TA20. TA20 mRNA 
began to increase between embryonic days 13 and 
16. TA20 mRNA was observed mainly in neocor-
tical, hippocampal and precerebellar neuroepithe-
lium on embryonic day 16. Although the level of 
T A20 mRN A in the cerebral cortex was higher 
before birth than after birth, the level in cerebellar 
Purkinje cells increased gradually even after birth. 
The high expression level of T A20 mRN A in the 
hippocampus was maintained before and after birth. 
Thus, T A20 was expressed highly in brain regions 
in which neurons were changing morphologically 
and qualitatively, suggesting that T A20 may be 
involved in neuronal formation in vivo. 
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